Skip to main content
. 2022 May 18;17(5):e0268568. doi: 10.1371/journal.pone.0268568

Table 3. Log predicted remimazolam concentration in SP and LPF(-) groups.

Variables SP LPF(-) P value
Patients, n 34 15
At the end of remimazolam infusion, log M -6.33 (-6.44—-6.21) -6.44 (-6.53—-6.30) 0.112
At the end of extubation, log M -6.61 (-6.74—-6.45) -6.85 (-6.95—-6.76) 0.000 *
Difference of concentration, log M 0.26 (0.21–0.33) 0.41 (0.33–0.47) 0.000 *

Data are median (IQR; 25% ‒ 75% interquartile range).

*significant difference.

SP, short period (time to extubation < 15 min); LPF(-), long period (time to extubation ≥ 15 min) without flumazenil.